FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

3752811000001108: Isocarboxazid 10mg tablets (Cambridge Laboratories) 56 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
26123901000001113 Isocarboxazid 10mg tablets (Cambridge Laboratories) 56 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
61512101000001112 Isocarboxazid 10mg tablets (Alliance Pharmaceuticals Ltd) 56 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Isocarboxazid 10mg tablets (Cambridge Laboratories) 56 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Isocarboxazid 10mg tablets (Cambridge Laboratories) 56 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Isocarboxazid 10mg tablets (Cambridge Laboratories) 56 tablet Has excipient Lactose false Inferred relationship Existential restriction modifier
Isocarboxazid 10mg tablets (Cambridge Laboratories) 56 tablet Is a Isocarboxazid 10mg tablets 56 tablet true Inferred relationship Existential restriction modifier
Isocarboxazid 10mg tablets (Cambridge Laboratories) 56 tablet Is pack of Isocarboxazid 10mg tablets (Cambridge Laboratories) false Inferred relationship Existential restriction modifier
Isocarboxazid 10mg tablets (Cambridge Laboratories) 56 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Isocarboxazid 10mg tablets (Cambridge Laboratories) 56 tablet Has active ingredient Isocarboxazid false Inferred relationship Existential restriction modifier
Isocarboxazid 10mg tablets (Cambridge Laboratories) 56 tablet Has excipient Excipient not declared false Inferred relationship Existential restriction modifier
Isocarboxazid 10mg tablets (Cambridge Laboratories) 56 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Isocarboxazid 10mg tablets (Cambridge Laboratories) 56 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Isocarboxazid 10mg tablets (Cambridge Laboratories) 56 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Isocarboxazid 10mg tablets (Cambridge Laboratories) 56 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Isocarboxazid 10mg tablets (Cambridge Laboratories) 56 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Isocarboxazid 10mg tablets (Cambridge Laboratories) 56 tablet Has AMP Isocarboxazid 10mg tablets (Cambridge Laboratories) true Inferred relationship Existential restriction modifier
Isocarboxazid 10mg tablets (Cambridge Laboratories) 56 tablet Has specific active ingredient Isocarboxazid true Inferred relationship Existential restriction modifier
Isocarboxazid 10mg tablets (Cambridge Laboratories) 56 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Isocarboxazid 10mg tablets (Cambridge Laboratories) 56 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start